ConvAHKG:基于行动的混合知识图,采用双通道卷积方法用于药物重定向
Marzieh Khodadadi AghGhaleh1,2, Rooholah Abedian3, Reza Zarghami2
1Laboratory of Bioinformatics and Drug Design (LBD), Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran.
ConvAHKG是一种新的知识图方法,通过预测药物与疾病的关联来增强药物重定向. 它确定了非小细胞肺癌等疾病的潜在新疗法,提高了药物发现效率.
科学领域:
- 计算生物学和生物信息学
- 药物的发现和开发.
- 医学中的人工智能.
背景情况:
- 药物再利用加速了对现有药物的新疗法应用的识别,减少了开发时间和成本.
- 预测药物与疾病的关联对于有效的药物再利用至关重要,但由于数据的复杂性和阶级不平衡,它面临着挑战.
研究的目的:
- 提出ConvAHKG,一种基于行动的混合知识图方法,用于更好地预测药物和疾病的关联.
- 为了利用生物关系,并整合药物/疾病特征,为一个全面的药物重定向框架.
- 解决药物疾病数据集中的阶级不平衡问题,提高预测性能.
主要方法:
- 使用Word2Vec嵌入式来捕捉生物实体 (药物,蛋白质,疾病) 之间的语义相似性.
- 引入了一种新的双通道1D卷积神经网络 (IDC_Conv1D),用于分类药物疾病对.
- 实现了一个加权的二进制交叉损失函数,以减轻类不平衡问题.
主要成果:
- 与最先进的模型相比,ConvAHKG实现了更高的性能,曲线下的面积 (AUC) 为0.9836和精度回忆曲线下的面积 (AUPRC) 为0.9686.6.
- 该框架成功地确定了非小细胞肺癌 (NSCLC) 的有希望的治疗候选者,包括Trastuzumab.
- 分子对接分析支持预测化合物的潜力作为一种新的NSCLC治疗选择.
结论:
- ConvAHKG为药物重新定位和预测药物疾病关联提供了一种强大而有效的方法.
- 该方法显示了识别新型治疗策略的巨大潜力,特别是对于像NSCLC这样的复杂疾病.
- 该研究提供了一个经过验证的计算框架和开源资源,用于推进药物发现工作.
更多相关视频
07:35A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
Published on: October 13, 2023
05:47Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
Published on: June 13, 2025
相关概念视频
Antihypertensive Drugs: Action of Calcium Channel Blockers
Principles of Drug Action
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Antihypertensive Drugs: Action of Diuretics
Convolution Properties II
The width property indicates that if the durations of input signals are T1 and T2, then the width of the output response equals the sum of both durations, irrespective of the shapes of the two functions. For instance, convolving two rectangular pulses with durations of 2 seconds and 1 second results in a function with a width of 3 seconds.
The area property asserts that the area under the...
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Neurochemical Transmission: Sites of Drug Action
